ArticlePrenatal diagnosis2025
Fetal Endoscopic Tracheal Occlusion (FETO) for Left and Right Congenital Diaphragmatic Hernia in Canada.
Article in Prenatal diagnosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Latin American Multicenter Study of Fetal Endoscopic Tracheal Occlusion for Severe Left Diaphragmatic Hernia.Prenatal diagnosis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe perinatal and short-term pediatric outcomes and procedural safety of fetal endoscopic tracheal occlusion (FETO) in a Canadian national referral centre.
methodsRetrospective study including all consecutive FETO cases at the Ontario Fetal Centre between 2010 and 2024. Maternal and fetal baseline characteristics, technical aspects and short-term outcomes until 6 months are described.
resultsFETO was successfully performed in 47/48 (98%) cases at an average gestational age (GA) of 28.5 (24-31.6) weeks including 22 (47%) moderate LCDH (M-LCDH), 12 (25%) severe LCDH (S-LCDH) and 13 (28%) right CDH (RCDH). There were no major complications. Balloon removals were emergent in 23/46 (50%) and challenging in 14/46 (30%) of cases. Preterm premature rupture of membranes (< 37 weeks) occurred in 70% (33/47) with average GA at birth of 35.9 weeks (29.0-40.4 weeks). Survival to discharge was 54% (25/46), specifically 64% (14/22), 33% (4/12), and 58% (7/12) among M-LCDH, S-LCDH and RCDH, respectively. Patch repair was performed in 28/30 (93%). Supplemental oxygen and tube feeding were required in 32% (8/25) and 68% (15/22) of survivors at discharge, respectively.
conclusionsIn this North American series, FETO outcomes were similar to those observed in international trials, confirming its effectiveness. Studies are ongoing to evaluate long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.